Ascendis Pharma A (ASND) Operating Expenses (2016 - 2025)
Historic Operating Expenses for Ascendis Pharma A (ASND) over the last 12 years, with Q3 2025 value amounting to -$210.8 million.
- Ascendis Pharma A's Operating Expenses fell 3385.27% to -$210.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158.9 million, marking a year-over-year increase of 5704.5%. This contributed to the annual value of -$31.4 million for FY2024, which is 4823.82% up from last year.
- Ascendis Pharma A's Operating Expenses amounted to -$210.8 million in Q3 2025, which was down 3385.27% from $203.2 million recorded in Q2 2025.
- Over the past 5 years, Ascendis Pharma A's Operating Expenses peaked at $203.2 million during Q2 2025, and registered a low of -$210.8 million during Q3 2025.
- Its 5-year average for Operating Expenses is $77.3 million, with a median of $149.3 million in 2024.
- Per our database at Business Quant, Ascendis Pharma A's Operating Expenses soared by 28164.64% in 2021 and then plummeted by 18262.82% in 2024.
- Quarter analysis of 5 years shows Ascendis Pharma A's Operating Expenses stood at -$132.5 million in 2021, then increased by 26.52% to -$97.4 million in 2022, then surged by 37.74% to -$60.6 million in 2023, then surged by 48.9% to -$31.0 million in 2024, then crashed by 580.09% to -$210.8 million in 2025.
- Its last three reported values are -$210.8 million in Q3 2025, $203.2 million for Q2 2025, and $197.4 million during Q1 2025.